Arch Oncology is the older company (2006 vs 2021); Orbis Medicines is the larger of the two.
Side-by-Side Comparison
| Metric | Arch Oncology | Orbis Medicines |
|---|---|---|
| Founded | ||
| Founded | 2006 older | 2021 |
| Headquarters | ||
| Headquarters | Brisbane, United States | Denmark |
| Employees | ||
| Employees | 7 | 47 larger |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Series C | Series A |
| Total Funding | ||
| Total Funding | $250.40M | $116.00M |
| Funding Rounds | ||
| Funding Rounds | 5 | 4 |
| Services | ||
| Services | Not tracked yet | Development of oral macrocycle drug candidates, Exploration and optimization of macrocycle chemical space, Integration of AI and large-scale data for drug discovery, Collaborative research and licensing agreements |
| Target Customers | ||
| Target Customers | Not tracked yet | Healthcare Providers, Pharmaceutical Companies, Biotechnology Researchers, Patients requiring biologic drug alternatives |
| Taxonomy | ||
| Taxonomy | Immuno-oncology, Antibody Therapies, Clinical-stage, Phase 1/2 Trials, Solid Tumors, Hematologic Malignancies, Anti-CD47 Antibodies, Cancer Treatment, Drug Development, Macrophages, St. Louis, MO, Brisbane, CA, Tumor Microenvironment, Scientific Research | Drug Discovery, Macrocyclic Chemistry, Computational Platform, High-throughput Screening, Challenging Targets, Pharmaceutical Innovation, Platform Development, Drug Candidates, Medicinal Chemistry, Targeted Therapy, Biopharmaceuticals, Chemoinformatics |
| Website | ||
| Website | archoncology.com | orbismedicines.com |
About Arch Oncology
Arch Oncology is a biotechnology company founded in 2006 and based in the United States. The company is primarily focused on developing groundbreaking antibody therapies for the treatment of solid tumors and hematologic malignancies. Their lead product candidate AO-176 is currently in Phase 1/2 clin...
About Orbis Medicines
Orbis Medicines, founded in 2021, is at the forefront of transforming drug discovery. With the slogan "Reshaping the future of drug discovery," the company is dedicated to developing a comprehensive platform designed to discover, develop, and deliver drug candidates targeting challenging medical con...
We will tell you when either one moves
BounceWatch watches Arch Oncology and Orbis Medicines for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Arch Oncology and Orbis Medicines — by email.
Frequently Asked Questions
Compare Arch Oncology with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Arch Oncology on 12 Sep 2024, and Orbis Medicines on 21 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
